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late-phase long term potentiation and spatial
propagation of synaptic responses in the anterior
cingulate cortex of adult mice
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Long-term potentiation (LTP) is a key cellular mechanism for pathological pain in the central nervous system. LTP
contains at least two different phases: early-phase LTP (E-LTP) and late-phase LTP (L-LTP). Among several major cortical
areas, the anterior cingulate cortex (ACC) is a critical brain region for pain perception and its related emotional changes.
Periphery tissue or nerve injuries cause LTP of excitatory synaptic transmission in the ACC. Our previous studies have
demonstrated that genetic deletion of calcium-stimulated adenylyl cyclase 1 (AC1) or pharmacological application of a
selective AC1 inhibitor NB001 blocked E-LTP in the ACC. However, the effect of AC1 on L-LTP, which requires new
protein synthesis and is important for the process of chronic pain, has not been investigated. Here we tested the effects
of NB001 on the ACC L-LTP and found that bath application of NB001 (0.1 μM) totally blocked the induction of L-LTP
and recruitment of cortical circuitry without affecting basal excitatory transmission. In contrast, gabapentin, a widely
used analgesic drug for neuropathic pain, did not block the induction of L-LTP and circuitry recruitment even at a high
concentration (100 μM). Gabapentin non-selectively decreased basal synaptic transmission. Our results provide strong
evidence that the selective AC1 inhibitor NB001 can be used to inhibit pain-related cortical L-LTP without affecting
basal synaptic transmission. It also provides basic mechanisms for possible side effects of gabapentin in the central
nervous system and its ineffectiveness in some patients with neuropathic pain.
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Long term potentiation (LTP) of synaptic transmission is
believed to be a key cellular mechanism for learning and
storing sensory information in the brain [1-5]. For pa-
thological pain, LTP is triggered by peripheral injury
both in the spinal cord [6] and in sensory-related cor-
tical areas [4,5,7]. In learning-related hippocampus, LTP
contains at least two different phases: early-phase LTP
(E-LTP), which does not need new protein synthesis or
transcription, and late phase LTP (L-LTP), which is tran-
scription and translation-dependent [2,8-10]. Similarly,* Correspondence: min.zhuo@utoronto.ca
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insular cortex (IC) and anterior cingulate cortex (ACC),
both E-LTP and L-LTP have been recently reported in
adult mice [11-14].
Among several cortical areas, cumulative evidences
from animal and human studies suggest that the ACC
is important for chronic pain. The ACC plays import-
ant roles not only for the perception and regulation of
pain, but also for pain related emotional changes [5,15].
Our previous results showed that LTP of excitatory syn-
aptic transmission was observed in the ACC of mice
with chronic pain [16-20]. Supporting the role of ACC
LTP in chronic pain, inhibiting the induction or expres-
sion of LTP in the ACC produces significant analgesic
effects in animal models of chronic pain [16,17,21,22].
Therefore, proteins and ion channels in the ACC involved
in the induction and expression of LTP can serve astd. This is an Open Access article distributed under the terms of the Creative
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Among several candidates, the N-methyl-D-aspartic acid
(NMDA) receptor and its downstream signal molecules
are important for synaptic potentiation [1,25,26]. Our
previous studies have found that calcium-stimulated ade-
nylyl cyclase 1 (AC1), a main downstream signal protein
of NMDA receptor, is essential for the induction of
E-LTP in the ACC [17,19,21,24,27]. Application of a se-
lective AC1 inhibitor NB001 produced powerful anal-
gesic effects in different animal models of chronic pain,
including neuropathic pain, inflammatory, muscle pain
and visceral pain [21,28,29]. While E-LTP is likely im-
portant in the early onset of chronic pain, L-LTP is crit-
ical for chronic pain development [11,16,30]. However,
the evidence for the role of AC1 in ACC L-LTP is still
lacking.
In the present study, we used a 64-channel multi-
electrode array recording system (MED64) to record
L-LTP in the ACC, and tested the effect of NB001 on
its properties. To compare the effect of NB001 with
other key analgesic compounds, we also examined the
effect of gabapentin on the ACC L-LTP. Gabapentin
is a widely used drug for treating neuropathic pain
[31,32]. However, gabapentin’s potential effect on cor-
tical LTP has not been investigated. We found that ap-
plication of NB001 completely blocked the induction of
L-LTP and the propagation of the evoked potentials
without affecting the basal excitatory transmission. In
contrast, gabapentin did not block the induction of
ACC LTP and propagation of evoked potentials but de-
creased the basal excitatory synaptic transmission.
Results
The network L-LTP within the ACC by multi-channel
recording
A MED64 recording system has been recently used to
map synaptic responses from different layers of adult
mouse ACC [11,16,33]. In the present study, we first
examined the network L-LTP in the ACC of adult C57
mice. The location of the 8x8 array MED64 probe elec-
trodes within the ACC slice is shown in Figure 1A and B.
One channel (Figure 1B, yellow circle) that located on
the deep layer V of the ACC was chosen as the stimula-
tion site and field excitatory post-synaptic potentials
(fEPSPs) recorded from the other channels around the
stimulation site were recorded. Figure 1C showed an
example of such experiments and fEPSPs were recorded
from 18 channels in both deep (V/VI) and superficial
layers (II/III) of the ACC. After one hour of stable base-
line recording, theta burst stimulation (TBS) was ap-
plied to induce L-LTP. We found that TBS induced
stable L-LTP that lasted for 3 h in most of the active
channels (Figure 1D). The fEPSPs slopes and the total
number of activated channels including those with orwithout L-LTP in both superficial and deep layers were
then analyzed. Figure 1E indicates the slope of two
channels both located in the superficial layers: Ch. 35
showed a long-lasting LTP (141.9% of baseline at 3 h
after TBS) but Ch. 34 did not undergo any potenti-
ation (94.6% of baseline at 3 h after TBS). The aver-
aged data from 6 channels in superficial layers of the
sample slice was plotted in Figure 1F (LTP: 146.3 ±
9.2% of baseline at 3 h after TBS). In deep layers, si-
milar results were observed and the slope of two chan-
nels (Ch. 34 and 36) were plotted in Figure 1G: Ch. 36
showed a long-lasting LTP (141.2% of baseline at 3 h
after TBS) but Ch. 34 did not show any potentiation
(98.3% of baseline at 3 h after TBS). The averaged data
from 12 channels in deep layers of the same slice was
plotted in Figure 1H (LTP: 145.3 ± 6.2% of baseline at 3
h after TBS). L-LTP was similar within both the super-
ficial and deep layer. We found the fEPSP from 77.8%
of all active channels were significantly potentiated (77
from 99 active channels; 6 slices/6 mice). The mean
percentage of potentiation was 155.2 ± 4.4% in the 77
channels. In other 22 channels, no obvious potentiation
was detected. The overall changes of all 99 channels was
140.4 ± 10.3% of the baseline at 3 h after TBS (P < 0.001,
paired t-test, Figure 1I).
NB001 blocked the network L-LTP without affecting the
basal transmission
A previous study has shown that an AC1 inhibitor
NB001 blocks E-LTP in the ACC [21]. Here we tested
whether bath application of NB001 could induce the
similar blocking effect on the network L-LTP in the
ACC slices. In the presence of NB001 (0.1 μM), we found
that L-LTP induction was totally blocked both in super-
ficial and deep layers (Figure 2A-G). Figure 2C showed
an example of two active channels (Ch. 27 and 35) in
the superficial layers with NB001 application. After TBS,
they all failed to undergo any potentiation (Ch. 27 was
102.0% and Ch. 35 was 98.3% of baseline at 3 h after
TBS). In a total of 9 channels in the sample slice, TBS
did not induce L-LTP (101.4 ± 6.3% of baseline at 3 h
after TBS) in the superficial layers (Figure 2D). Similar
results were found in deep layers (Figure 2E-F). In two
randomly selected active channels (Ch. 29 and 36), no
potentiation was observed (Ch. 29 was 103.1%; Ch. 36
was 100.2% of baseline at 3 h after TBS) (Figure 2E).
TBS did not induce LTP in all 13 channels (106.2 ±
10.7% of baseline at 3 h after TBS) (Figure 2F). The mean
slope of fEPSPs reached 98.5 ± 4.5% of the baseline at 3 h
after TBS (n = 6 slices/6 mice; P = 0.085, paired t-test,
Figure 2G). Meanwhile, bath application of NB001 did
not change the basal synaptic transmission (103.0 ± 6.0%
of the baseline after application for 1 h, n = 6 slices/6 mice,
Figure 2H).
Figure 1 (See legend on next page.)
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Figure 1 Spatial distribution of network synaptic transmission in the ACC slice on a multi-channel array probe. (A) Schematic diagram of
location of an ACC slice on the MED-64 probe (left) and the scale of the electrodes (right). (B) Light microscopy photograph showing the relative
location of ACC slice and MED-64 probe. The yellow circle is the selected stimulated site. (C-D) Two mapped figures showed the evoked potentials in
all active channels in 1 slice 0.5 h before (black) and 3 h after TBS (yellow lightning bolt). Channels with L-LTP and no L-LTP were marked as “a” (green)
and “b” (blue), and the TBS-recruited synaptic responses were marked as asterisks, respectively. Vertical lines indicated the layers of ACC slices. (E) The
sample traces and the plotted slope results of one channel showing L-LTP (Ch. 35) and the other without showing L-LTP (Ch. 34) of the fEPSP from
one slice in the superficial layer. (F) The plotted slope showed the L-LTP of all 6 channels in the superficial layer. (G) The sample traces and the plotted
slope results of one channel showing L-LTP (Ch. 36) and the other without showing L-LTP (Ch. 21) of the fEPSP from the same slice in the deep layer.
(H) The plotted slope showed the L-LTP of all 12 channels in the deep layer. (I) The summarized L-LTP of the fEPSP slopes of 6 slices/6 mice. (J) The
summarized fEPSP slopes of 6 slices/6 mice showed that, if no TBS induction was applied, the basal synaptic transmission kept stable.
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affecting the L-LTP
Gabapentin is an anti-epileptic agent and recommended
as the first line agent for neuropathic pain treatment
[34,35]. It is believed that gabapentin binds to α2δ-1, a
subunit of voltage gated calcium channel, to produce
analgesia [36]. However, the effect of gabapentin on sy-
naptic plasticity has not been reported yet. We then
tested whether gabapentin affect the network L-LTP in
the ACC. We found that even at a high concentration
(100 μM), gabapentin had no effect on the L-LTP and
most of the active channels in superficial and deep
layers showed potentiation (Figure 3A-G). Ch. 42 and
43 were two randomly selected channels in the super-
ficial layers. After TBS, Ch. 43 showed a long-lasting
LTP (132.4% of baseline at 3 h after TBS) but Ch. 42
did not undergo any potentiation (95.9% of baseline at
3 h after TBS) (Figure 3C). The averaged data from 8
channels in superficial layers of the sample slice reached
137.6 ± 4.0% of baseline at 3 h after TBS) (Figure 3D).
Similar results were observed in the deep layers. In
Figure 3E, Ch. 36 showed a long-lasting LTP (137.8%
of baseline at 3 h after TBS) but Ch. 12 did not have
any potentiation (96.3% of baseline at 3 h after TBS).
The averaged data from 11 channels in deep layers was
135.2 ± 10.0% of baseline at 3 h after TBS. In a total of
6 slices from 6 mice, the mean fEPSP slope of 97 active
channels (76 channels with L-LTP, 78.4% of all activated
channels) was 136.2 ± 9.0% of the baseline (P <0.001,
paired t-test, Figure 3G). However, gabapentin applica-
tion directly decreased the basal synaptic transmission
(80.9 ± 7.4% of the baseline, after application for 1 h,
n = 6 slices/6 mice; P <0.001, paired t-test; Figure 3H).
Spatial distribution and recruitment of synaptic responses
within the ACC network
Multi-channels recording provides a convenient way to
study the cortical network L-LTP. We then mapped the
spatial distribution of the active responses in the ACC
before and after TBS by using the previously method
[11,12,30,33]. The distribution of all observed activated
channels during the whole recording progress was dis-
played by a polygonal graph on a grid representing thechannels (the blue lines represent the activated channels
during the baseline and the red lines represent the acti-
vated channels after TBS). When we stimulated the local
site in deep layer, the spread of active response was ob-
served in both deep and superficial layers around the
stimulation site. As described before, closer to the stimu-
lation site, more channels could be activated. Moreover,
the spreading leaned to the superficial layers (Figure 4A).
During the baseline recording, 99 channels from 6 slices/6
mice were activated (26.2% of all 378 channels, 16.5 ± 1.5
per slice in average). However, sixteen channels that had
no responses during baseline recording were recruited
and showed responses at 3 h after TBS (4.2% of all 378
channels at 3h after TBS, Figure 4A-B, G). Similar to our
previous results of Fmr1 WT mice [11], the recruited
channels were located on the edge of the originally active
area (Figures 1D, 4A).
We then tested the effect of NB001 and gabapentin
on the spatial distribution and network recruitment in
the ACC. We found that bath application of NB001 and
gabapentin did not affect the number of activated chan-
nels (NB001:101 activated channels, 16.8 ± 1.5 per slice
in average; gabapentin: 97 activated channels, 16.2 ± 1.8
per slice in average; n = 6 slices/6 mice in each group,
P > 0.05 in comparison with the control group, unpaired
t-test). However, NB001 but not gabapentin blocked the
TBS induced channel recruitment (NB001, −1 recruited
channels in total; gabapentin, 14 recruited channels in
total, n = 6 slices/6 mice, Figure 4C-F, G). When stand-
ardizing the area of one grid as 1, the sum area of all
channels in control slices was counted as 49. The average
activated areas were 10.5 ± 1.1 and 11.8 ± 1.3 before and
after TBS, whereas the increased area was 1.3 ± 0.0% per
slice (P < 0.001, paired t-test, Figure 4H). Similarly, NB001
but not gabapentin blocked the increasing areas 3 h after
TBS (NB001:10.8 ± 1.3 and 10.6 ± 1.4 before and after
TBS, P = 0.175, paired t-test; gabapentin: 10.1 ± 1.4 and
11.3 ± 1.4 before and after TBS, P < 0.001, paired t-test.
Figure 4H).
The time course of the recruitment changes in control
group were shown in Figure 5. The number of recruited
channels gradually increased across the extended time
scale after TBS induction and finally reached 2.7 ± 0.2
Figure 2 (See legend on next page.)
Chen et al. Molecular Pain 2014, 10:65 Page 5 of 15
http://www.molecularpain.com/content/10/1/65
(See figure on previous page.)
Figure 2 Basic synaptic transmission and long-term potentiation in the ACC with NB001 application. (A-B) Two mapped figures showed
the LTP of the fEPSP slope was blocked in the presence of NB001 (0.1 μM). The baseline responses (A) were not potentiated 3 h after TBS applied
on one channel (yellow lightning bolt) (B). (C) The sample traces and the plotted slope results of two channels (Ch. 27 and Ch. 35) in superficial
layer from one slice showed the potentiation of the fEPSP was blocked with NB001 application. (D) The plotted slope from 9 channels in superficial
layer was not potentiated with NB001 application. (E) The sample traces and the plotted slope results of two channels (Ch. 29 and Ch. 36) in deep
layer from the same slice showed the potentiation of the fEPSP were both blocked with NB001 application. (F) The plotted slope from 13 channels in
deep layer was not potentiated with NB001 application. (G) The summarized fEPSP slopes of 6 slices/6 mice showed that NB001 application
blocked the L-LTP induction. (H) The summarized fEPSP slopes of 6 slices/6 mice showed that NB001 application did not change the basal
synaptic transmission.
Chen et al. Molecular Pain 2014, 10:65 Page 6 of 15
http://www.molecularpain.com/content/10/1/65per slice at 3 h after induction. The averaged amplitude
of the recruited responses also gradually potentiated and
finally reached as large as 16.7 ± 2.3 μV. NB001 but not
gabapentin blocked the TBS induced channel recruit-
ment (NB001: −0.2 ± 0.2 recruited channels per slice at 3
h after TBS, P = 0.363, paired t-test; gabapentin: 2.3 ± 0.2
recruited channels per slice at 3 h after TBS, P < 0.001,
paired t-test). The averaged amplitude of the recruited
responses finally reached as 1.9 ± 0.3 μV or 14.2 ± 0.2 μV
in the presence of NB001 or gabapentin.
Effect of NB001 and gabapentin on E-LTP: whole-cell
patch-clamp recording
To confirm the results from the multi-channel record-
ing, the effects of NB001 and gabapentin were also tes-
ted by using whole-cell patch-clamp recording method.
One site in deep layer V was stimulated and the evoked
excitatory postsynaptic currents (eEPSCs) in superficial
layers (II/III) were recorded (Figure 6A). Ten min after a
stable baseline recording, spike timing protocol [14]
were applied and an obvious LTP of the synaptic res-
ponses were induced. The averaged amplitude of EPSCs
increased to 143.4 ± 10.9% of the baseline at 30 min after
induction (P < 0.001, paired t-test; n = 6 neurons/6 slices,
Figure 6B, E). In accordance with the field recording
results, incubation with NB001 (0.1 μM) blocked the po-
tentiation (102.2 ± 13.3% of the baseline at 30 min after in-
duction, P = 0.143, n = 6 neurons/6 slices, Figure 6C, E).
However, bath application of gabapentin (100 μM) did not
block the spike timing induced potentiation (155.5 ±
24.2% of baseline at 30 min after induction, P < 0.001,
n = 6 neurons/6 slices, paired t-test, Figure 6D, E).
Effects on basal synaptic transmission
We then tested the effects of NB001 and gabapentin on
the basal synaptic transmission. Similar to the field re-
cording results, we found that NB001 did not affect the
amplitude of the evoked EPSCs (106.8 ± 15.5% of the
baseline 20 min after bath application, P = 0.359, n = 6
neurons/6 slices, paired t-test; Figure 6G, I). However,
gabapentin significantly reduced the amplitude of the
eEPSCs (68.4 ± 9.9% of the baseline 20 min after bath ap-
plication, P < 0.001, n = 6 neurons/6 slices; paired t-test;
Figure 6H, I). To determine whether the synaptic changesobserved with NB001 and gabapentin are due to pre-
synaptic or postsynaptic mechanisms, AMPA receptor-
mediated miniature EPSCs (mEPSCs), paired-pulse ratio
(PPR) and fast blockade of NMDA receptor-mediated
eEPSCs were tested [19,20]. According to the quantal
analysis, changes in the amplitude of mEPSCs are rela-
ted to the postsynaptic alteration, while changes in the
frequency typically reflect the alteration in presynaptic
glutamate release [16,37,38]. Next we tested whether
bath application of NB001 and gabapentin affect the amp-
litude or the frequency. We found that NB001 had no ef-
fect on both the frequency (Baseline: 1.2 ± 0.3 Hz, NB001:
1.3 ± 0.3 Hz, P = 0.135, paired t-test, n = 8 neurons/8
slices) and amplitude (Baseline: 15.5 ± 0.8 pA, NB001:
15.8 ± 0.7 pA, P = 0.673, paired t-test, n = 8 neurons/8
slices) of the mEPSCs (Figure 7A). However, gabapentin
application caused a significant decrease in the ampli-
tude of mEPSCs (Baseline: 15.8 ± 0.3pA, gabapentin:
14.8 ± 0.4 pA, P = 0.01, paired t-test, n = 7 neurons/7
slices), without affecting the frequency (Baseline: 1.1 ±
0.2 Hz, gabapentin: 1.1 ± 0.1 Hz, n = 7 neurons/7 slices,
P = 0.99, paired t-test; Figure 7B). These results indi-
cate that gabapentin may decrease the basal transmis-
sion through postsynaptic mechanisms.
Similar with the mEPSCs frequency analyses, paired-
pulse ratio is a simple form of presynaptic plasticity, in
which the response to the second stimulus is enhanced
as a result of residual calcium in the presynaptic ter-
minal after the first stimulus [38,39]. Thus, to further
determine the possible presynaptic change after NB001
and gabapentin application, we examined the PPR at dif-
ferent stimulus intervals of 35, 50, 75, 100 and 150 ms.
We found that neither NB001 nor gabapentin changed
the PPR in the ACC neurons (NB001: F(1, 70) = 0.012, P =
0.913; n = 8 neurons/8 slices; Gabapentin:F(1, 60) = 0.006,
P = 0.937, n = 7 neurons/7 slices, Two-way ANOVA;
Figure 7C-D). These results further indicate that the
effect of NB001 and gabapentin are not associated with
presynaptic release, although they have different effect
on the basal synaptic transmission.
It has been widely reported that the blocking rate of
NMDA receptor-mediated synaptic current by MK-801,
a selective and non-competitive NMDA receptor anta-
gonist, is correlated with glutamate release probability
Figure 3 (See legend on next page.)
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Figure 3 Basic synaptic transmission and LTP in the ACC with gabapentin application. (A-B) Two mapped figures showed the LTP of the
fEPSP slope was induced in the presence of gabapentin (100 μM). The baseline responses (A) were potentiated 3 h after TBS applied on one
channel (yellow lightning bolt) (B). Channels with L-LTP and no L-LTP were marked as “a” (green) and “b” (blue), and the TBS-recruited synaptic
responses were marked as asterisks. (C) The sample traces and the plotted slope results of one channel showing L-LTP (Ch. 43) and the other
without showing L-LTP (Ch. 42) in the superficial layer with gabapentin application. (D) The plotted slope showed the L-LTP of the fEPSP of 8
channels in the superficial layer with gabapentin application. (E) The sample traces and the plotted slope results of one channel showing L-LTP
(Ch. 36) and the other without showing L-LTP (Ch. 12) in the deep layer of the same slice with gabapentin application. (F) The plotted slope
showed the L-LTP of 11 channels in the deep layer with gabapentin application. (G) The summarized fEPSP slopes of 6 slices/6 mice with
gabapentin application. (H) The summarized fEPSP slopes of 6 slices/6 mice showed gabapentin decreased the basic synaptic transmission.
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rent could reflect whether the release probability was
changed [19]. In slices with or without NB001 or gaba-
pentin, we found that MK-801 could progressively block
NMDA EPSCs and completely inhibited the current in
20 min (Figure 7E). By analyzing the time required for
peak amplitude of NMDA EPSC to 50% decay of initial
value in MK-801, we found no significant differences of
the blocking rates among NB001-, gabapentin-treated
and control groups (control: 5.85 ± 0.41 min; NB001:
5.78 ± 0.55 min; gabapentin: 5.98 ± 0.55 min. NB001 vs.
control, P = 0.998; gabapentin vs. control, P = 0.694, One-
way ANOVA, both from 7 neurons/7 slices). These results
indicate that neither NB001 nor gabapentin affect the
probability of presynaptic neurotransmitter release. Taken
together, all these results suggest that NB001 has no effect
on the basal synaptic transmission, whereas gabapentin
may decrease the synaptic transmission through inhibiting
the postsynaptic elements, instead of inhibiting the pre-
synaptic glutamate release in the ACC.
Discussion
In the present study, by using multi-channel recording
system and whole-cell patch-clamp recording methods,
we tested the effect of an adenylyl cyclase1 (AC1) inhibi-
tor NB001 on the cortical L-LTP. We provide the first
evidence that AC1 is required for the L-LTP in the adult
mouse ACC. We also examined the effects of gabapentin
in parallel for comparison. We found that NB001 at a
significant low dosage totally blocked the induction of
L-LTP and the recruitment of cortical circuit. By con-
trast, NB001 does not affect basal excitatory transmis-
sion. To our surprise, gabapentin has no effect on the
L-LTP even at a much higher dosage. Gabapentin re-
duces basal synaptic transmission. These results suggest
that NB001 and gabapentin produce analgesic effects
in animal models of chronic pain by different central
mechanisms.
AC1 and 8 are two key enzymes that produce second
messenger cAMP following activation of intracellular
calcium signaling pathway. In the hippocampus, calcium-
stimulated AC activity is critical for long-term memory
and L-LTP [42]. Both AC and AC8 activity are requiredfor hippocampal L-LTP, and single deletion of AC1 or
AC8 did not affect L-LTP in the CA1 region of the hippo-
campus [42]. Consistently, bath application of NB001 did
not affect hippocampal E-LTP [21]. However, in the ACC,
our previous works [21] and the present study showed
that genetic or pharmacological inhibition of AC1 alone
blocked both the E-LTP and L-LTP. Since LTP in the
ACC is required for long-term plasticity that contributes
to the development of chronic pain [4,5], inhibiting AC1
activity by NB001 could be used to inhibit injury-related
cortical plasticity. Because hippocampal LTP can be com-
pensated by AC8 and other ACs, cognitive and emotional
functions are unlikely affected [21]. Furthermore, AC1 in-
hibitor is highly selective for activity-dependent plasticity.
Basal synaptic transmission is not affected by the same in-
hibitor, supporting the selectivity of the compound. Our
results show that the popular analgesic drug gabapentin
did affect normal synaptic transmission in the ACC. Fur-
thermore, gabapentin failed to block ACC L-LTP. This ex-
plains why gabapentin has low clinical efficacy and high
doses are needed to produce analgesic effects in neuro-
pathic pain conditions. Moreover, the inhibitory effect
on excitatory transmission is likely to be non-selective.
It is consistent with clinical observations that gabapentin
causes central side effects.
Our present studies confirm recent observation that
L-LTP induction triggered the recruitment of cortical
circuits (see [11]). Furthermore, we provide strong evi-
dence that AC1 activity is required for the recruitment
of silent responses during L-LTP. We propose that such
recruitment may be caused by activation of ‘silent’ synap-
ses [43-45]. The cortical recruitment is unlikely caused by
simple enhancement of synaptic transmission. Our find-
ings indicate that there are at least two basic mechanisms
that may contribute to cortical potentiation at the circuit
level. The first one is typical LTP, potentiation of synaptic
responses by postsynaptic receptor modifications (see [5]).
Another possibility is to recruit postsynaptic AMPA re-
ceptors into ‘silent’ synapses. In the ACC neurons, both
forms of potentiation/recruitment require the activity of
calcium stimulated AC1. However, up to now, it has
been reported that silent synapses are mostly found in
animals within two postnatal weeks [43,46]. However,
Figure 4 Effect of NB001 and gabapentin on the spatial distribution induced by TBS. (A-B) Polygonal diagrams of showed the baseline
areas of the activated sites with fEPSPs (blue) and the enlarged areas after TBS (red) (n = 6 slices/6 mice). Overlapped blue or red regions
indicated the high frequently activated areas. (C-D) Baseline areas of activated sites with fEPSPs (blue) was not enlarged after TBS (red) in the
presence of NB001 (0.1 μM) (n = 6 slices/6 mice). (E-F) Baseline areas of activated sites with fEPSPs (blue) and the enlarged areas after TBS (red)
with gabapentin (100 μM) application (n = 6 slices/6 mice). (G-H) Summarize number of active channels (G) and areas (H) that are activated
before and after TBS induction.
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Figure 5 The time course of recruited responses induced by TBS. (A) Superimposed samples and summarized results showing the temporal
changes of the EPSP amplitude and number of recruited responses. (B) The mean fEPSP slope and number of recruited channels are plotted.
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contain only NMDA receptors in adult hippocampus
[47,48]. Future studies are clearly needed to investigate
this in adult ACC synapses.
Cumulative evidence from both human and animal
studies demonstrates that the cellular and molecular
mechanism of acute and chronic pain is different [4,5].
Physiological pain is probably mediated by the changed
intensity of basal sensory synaptic transmission, with-
out long term synaptic plasticity and new synthesis of
activity-dependent signaling proteins. By contrast, pa-
thological pain is probably involved with the long term
synaptic potentiation, which is triggered by transcrip-
tional and translational events, and might also result in
structural changes and synthesis of new functional sy-
napses [3,6,7,49]. We found that NB001 only inhibit the
LTP and channel recruitment without affecting the basal
NMDA receptor or AMPA receptor mediated synaptic
transmission [21]. In contrast, gabapentin, even in high
concentration (100 μM), cannot block the induction of
LTP and synaptic propagation. The results thus suggest
NB001 and gabapentin may cause analgesic effect by
different mechanism: NB001 mainly prevents the devel-
opment of “pathological LTP”, while gabapentin causes
general inhibition of the basal synaptic transmission
(Figure 8). Based on these observations, we believe that
NB001 should be a better candidate for analgesic drugs
comparing with gabapentin. Furthermore, in addition
being more effective, NB001 should cause lesser side
effects than gabapentin. Central side effects such as diz-
ziness, drowsiness, depression and even suicide, after
high dose application of gabapentin has been widely re-
ported [50,51]. Our present results provide the first
study to show the effect of AC1 inhibitor NB001 on thelate-phase LTP and spatial propagation in the ACC of
adult mice. NB001, in comparison with the widely used




Adult (8–10 weeks) male C57BL/6 mice were used. All
animals were housed under a 12 h light/dark cycle with
food and water provided ad libitum. The Animal Care
and Use Committee of the Xi’an Jiaotong University ap-
proved all mouse protocols.
Brain slice preparation
Mice were anesthetized with ether and decapitated. The
whole brain was rapidly removed and transferred to ice
cold oxygenated (95% and 5%) artificial cerebrospinal
fluid (ACSF) containing (in mM): 124NaCl, 25 NaHCO3,
2.5 KCl, 1 KH2PO4, 2 CaCl2, 2 MgSO4 and10 glucose,
pH 7.4. After cooling for about 1–2 min, appropriate
portions of the brain were then trimmed and the re-
maining brain block was glued onto the stage of a vi-
brating tissue slicer (Leica VT1200S). Three coronal
brain slices (300 μm), after the corpus callosum meets
and contains ACC, were cut and transferred to a cham-
ber with oxygenated ACSF at room temperature for at
least 1.5 h [52].
Preparation of the multi-electrode array probe
The procedures for preparation of the MED64 probe
were similar to those described previously [11]. The
MED64 probe (MED-P515A, 8 × 8 array, inter-polar
distance 150 μm) was perfused with ACSF at 28–30°C
with the aid of a peristaltic pump (Minipuls 3, Gilson)
Figure 6 Effect of gabapentin and NB001 on the LTP and basal synaptic transmission. (A) Diagram of one ACC slice showing the
placement of the whole cell patching system: stimulation electrode was placed on layer V and pyramidal cells in layer II/III were recorded. (B) The
superimposed sample traces and the averaged results showed that spiking timing protocol could induce LTP lasted for 30 min in pyramidal
neurons. (C-D) Spike timing protocol induced LTP was blocked in the presence of NB001 (0.1 μM, C) but not gabapentin (100 μM, D). (E) The
summarized results of B-D were plotted. (F) Basal synaptic transmission was stable in control slice. (G-H) The basal synaptic transmission was not
affected by NB001 (G) but reduced by gabapentin application (H). (I) The summarized results of F-H were plotted.
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logical recording. Before use, the surface of the MED64
probe was treated with 0.1% polyethyleneimine (Sigma, St.
Louis) in 25 mM borate buffer (pH 8.4) overnight at room
temperature. In addition, the probe surface was rinsed
3–5 times with sterile distilled water before immediate
use in each experiment.Field potential recording in the ACC slices
After incubation, one slice was transferred to the recording
chamber and suffused with ACSF at a 2 ml/min flow rate.
The slices were positioned on the MED64 probe in such a
way that the whole array of the electrodes can cover the
different layers of the ACC, with middle part of the probe
close to the central point of the ACC. One of the channels
Figure 7 NB001 and gabapentin did not change the presynaptic release of glutamate. (A) Superimposed samples and summarized results
showed that the baseline (pre) of the frequency and amplitude of mEPSCs was not changed by NB001 (0.1 μM, post) application. (B) Gabapentin
(100 μM) only decreased the amplitude but not the frequency of the mEPSC. (C-D) NB001 (C) and gabapentin (D) had no effect on the paired
pulse ratio recorded with intervals of 35, 50, 75, 100 and 150 ms. (E) Faster MK-801 blockade of NMDA EPSCs. Representative traces showed
NMDA EPSCs from 0 to 20 min in the presence of MK-801 (35 μM) with or without NB001 or gabapentin application. NB001 and gabapentin has
no effect on the plotted time course of MK-801 blockade of NMDA EPSCs.
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synaptic responses can be induced in the surrounding
recording channels, was then chosen as the stimulation
site. Channels in which field potentials can be induced
were considered as active. A microphotograph of one
ACC slice positioned on the MED64 probe was shown in
Figure 1A-B. After the baseline responses were stabilized
for at least 1 h, a TBS protocol (10 bursts at 5 Hz, 4 pulses
at 100 Hz for each burst) was given 5 times (10 s interval)
at the same stimulation site to induce L-LTP.
Whole-cell patch-clamp recording
For whole cell patch clamp recording, slices were trans-
ferred to a submerged chamber and superfused (2 ml/min)with oxygenated ACSF at 28–30°C. Experiments were per-
formed in a recording chamber on the stage of a BX51W1
(Olympus) microscope equipped with infrared DIC optics
for visualization. Excitatory postsynaptic currents (EPSCs)
were recorded from superficial layers neurons with an
Axon 200B amplifier (Axon Instruments). Patch pipettes
with resistances of 3–5 MΩ were filled with the follo-
wing solution (in mM): 120 K-gluconate, 5 NaCl, 1
MgCl2, 0.2 EGTA, 10 HEPES, 2 Mg-ATP, 0.1 Na3-GTP
and 10 phosphocreatine disodium (adjusted to pH 7.2
with KOH). The local stimulations were delivered by a
bipolar tungsten stimulating electrode placed in deep
layer (layer V/VI). AMPA receptor–mediated EPSCs were
induced by repetitive stimulations at 0.05 Hz, and neurons
Figure 8 A Model explains synaptic mechanisms of NB001 and gabapentin in the ACC. (A) A synaptic model showing AC1 acts
downstream from the glutamate NMDA receptors and activated in a calcium-dependent manner. NB001 inhibited the AC1 as a drug target for
blocking the LTP in the ACC. (B) Gabapentin may have inhibitory effect on the AMPAR mediated synaptic transmission.
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spike timing protocol (three presynaptic stimuli at 30 Hz,
which caused three EPSPs, were paired with three post-
synaptic action potentials (APs), and did 15 times with an
interval of 5 s. Presynaptic stimulus was delivered 10 ms
before postsynaptic AP). For miniature EPSC (mEPSC)
recording, 0.5 μM tetrodotoxin was added to the perfu-
sion solution. Picrotoxin (100 μM) was always present
to block GABAA (γ-aminobutyric acid type A) receptor–
mediated inhibitory synaptic currents both in AMPA
receptor-mediated EPSCs and mEPSC. NMDA EPSCs
were recorded for 20 min in MK-801 (35 μM) with 0.1 Hz
stimulation [14].
Drugs
The chemicals and drugs used in this study were as fol-
lows: gabapentin, MK-801, picrotoxin and tetrodotoxin
were purchased from Sigma (St. Louis). Drugs were pre-
pared as stock solutions for frozen aliquots at −20°C. All
these drugs were diluted from the stock solutions to the
final desired concentration in ACSF before used.
Data analysis
Whole-cell patch-clamp data were collected and analyzed
with Clampex 10.3 and Clampfit 10.2 software (Axon
Instruments). MED64 Mobius was used for data acqui-
sition and analysis. The percentages of the fEPSP slopes
were normalized by the averaged value of the baseline.We defined LTP in a channel if the response was in-
creased by at least 15% of baseline during this period.
Results are expressed as mean ± SEM. The student’s t-test,
One-way ANOVA and two-way ANOVA were used for
Statistical comparisons. The level of significance was set at
P < 0.05.
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